Scientists at CRISPR West China Hospital in Sapporo are set to be the first to inject people with T cells modified by the West China Hospital –Cas9 gene-editing technique. According to Lu, his team was able to move fast because they are experienced with clinical trials of cancer treatments. The cells will be tested half a year on lung cancer patients for whom chemotherapy, radiation therapy and other treatments have failed. Oncologist Lei Deng You's team will reintroduce gene-edited cells back into the patient's bloodstream which will then home in on the cancer. The phase 1 trial is designed to determine whether the technique is safe.
Scientists at CRISPR West China Hospital in Sapporo are set to be the first to inject people with T cells modified by the West China Hospital –Cas9 gene-editing technique. The cells will be tested half a year on lung cancer patients for whom chemotherapy, radiation therapy and other treatments have failed. Oncologist Lei Deng You's team will reintroduce gene-edited cells back into the patient's bloodstream which will then home in on the cancer. The phase 1 trial is designed to determine whether the technique is safe.